Abstract：Objective To study the dosimetry parameters of 125I seed source (type Sinko BT-125-1) with thermoluminescent dosimeter (TLD) in the phantom. Methods The new type of phantom was modified to suit to measurement of a common type of 125I seed source. The AAPM TG43 protocol recommended measurements of dose-rate constant (Λ), radial dose function (gL(r)), and anisotropy function (F (r,θ)) have been performed in the phantom with TLD. Results The Λ was 0.928 cGyh－1U－1. The gL(r) was determined at different radial distances r ranging from 1.0 to 10.0 cm with an interval of 1.0 cm;and F (r,θ) at angles from 0° to 90° in 10° increments. The gL(r) of 125I seed source showed a difference of 9.6% at the most in comparison to the corresponding values of 125I seed source (type Amersham 6711). The difference in F(2 cm,θ) of 125I seed source and Amersham 6711 was up to 10.2% near the source end. With the phantom the combined standard uncertainty in the whole measurement was less than 6.0%. Conclusions The experimental results exhibit fairly small measurement uncertainties and good self-consistency. It′s feasible to measure the dosimetry characters of permanent implant seeds in the modified phantom.
Zhang Menglong,Song Shanjun,Wang Weipeng et al. Experimental determination of dosimetry parameters for Sinko 125I seed source using thermolumine-scent dosimeter[J]. Chinese Journal of Radiation Oncology, 2014, 23(2): 165-168.
[1] Chadwick E, Laing RW, Langley SEM. I-125 LDR prostate brachytherapy in a United Kingdom centre:evolution of a technique[J]. Brachytherapy,2011,10(Suppl 1):96. [2] Carey E, Manning M, Burney D, Radiation safety with permanent I-125 lung brachytherapy[J]. Brachytherapy,2008,7:164. [3] Rivard MJ, Coursey BM, DeWerd LA, et al. Update of AAPM task group No. 43 report:a revised AAPM protocol for brachytherapy dose calculations[J]. Med Phys,2004,31:633-674. [4] 张梦龙,孙尧,张良安,等.铱-192新源剂量学参数测量方法研究[J].中华放射肿瘤学杂志,2010,19:468-470. [5] Ling CC, Yorke ED, Spiro IJ, et al. Physical dosimetry of 125I seeds of a new design for interstitial implant[J]. Int J Radiat Oncol Biol Phys,1983,9:1747-1752. [6] Konnai1 A, Nariyama N, Ohnishi S, et al. Energy response of LiF and Mg2SiO4 TLDs to 10—150 keV monoenergetic photons[J]. Radiat Prot Dosim,2005,115:334-336. [7] Edwards CR, Mountford PJ, Green S, et al. The low energy X-ray response of the LiF:Mg:Cu:P thermoluminescent dosemeter:a comparison with LiF:Mg:Ti[J]. BJR,2005,78:543-547. [8] Sloboda RS, Menon GV. Experimental determination of the anisotropy function and anisotropy factor for model 6711 I-125 seeds[J]. Med Phys,2000,27:1789-1799. [9] Kennedy RM, Davis SD, Micka JA, et al. Experimental and Monte Carlo determination of the TG-43 dosimetric parameters for the 9011 THINSeedTM brachytherapy source[J]. Med Phys,2010,37:1681-1688. [10] Meigooni AS, Gearheart DM, Sowards K. Experimental determination of dosimetric characteristics of Best 125I brachytherapy source[J]. Med Phys,2000,27:2168-2173. [11] Anagnostopoulos G, Baltas D, Karaiskos P, et al. Thermoluminescent dosimetry of the SelectSeed 125I interstitial brachytherapy seed[J]. Med Phys,2002,29:709-715.
2014, Vol. 23 
